Lemaitre Vascular Inc(LMAT) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 28.07 | EPS (ttm) | 2.81 | Insider Own | 6.92% | Shs Outstand | 22.9M | Perf Week | -3.57% |
| Market Cap | 1.80B | Forward P/E | 24.79 | EPS next Y | 10.66% | Insider Trans | -3.91% | Shs Float | 21.3M | Perf Month | -4.88% |
| Enterprise Value | 1.62B | PEG | 2.22 | EPS next Q | 0.69 | Inst Own | 100.84% | Short Float | 7.56% | Perf Quarter | -14.66% |
| Income | 0.07B | P/S | 6.87 | EPS this Y | 13.99% | Inst Trans | 3.24% | Short Ratio | 4.42 | Perf Half Y | -27.27% |
| Sales | 0.26B | P/B | 4.29 | EPS next 5Y | 11.16% | ROA | 10.78% | Short Interest | 1.61M | Perf YTD | -2.84% |
| Book/sh | 18.38 | P/C | 4.79 | EPS past 3/5Y | 39.34% 19.43% | ROE | 16.77% | 52W High | -33.23% ($118.01) | Perf Year | -14.94% |
| Cash/sh | 16.45 | P/FCF | 24.41 | Sales past 3/5Y | 15.58% 14.05% | ROIC | 10.82% | 52W Low | 0.68% ($78.27) | Perf 3Y | 41.24% |
| Dividend Est. | $1 (1.27%) | EV/EBITDA | 18.4 | EPS Y/Y TTM | 38.09% | Gross Margin | 71.27% | Volatility(W/M) | 2.46% 2.46% | Perf 5Y | 33.45% |
| Dividend TTM | 0.95 | EV/Sales | 6.16 | Sales Y/Y TTM | 11.85% | Oper. Margin | 29.46% | ATR (14) | 2.57 | Perf 10Y | 288.18% |
| Dividend Ex-Date | 2026/8/20 | Quick Ratio | 13.96 | EPS Q/Q | 15.47% | Profit Margin | 25.02% | RSI (14) | 34.95 | Recom | 2 |
| Dividend Gr. 3/5Y | 16.96% 16.05% | Current Ratio | 15.89 | Sales Q/Q | 9.57% | SMA20 | -2.54% ($80.85) | Beta | 0.47 | Target Price | $107 |
| Payout | 31.77% | Debt/Eq | 0.45 | Earnings | 2026/8/4 | SMA50 | -13.16% ($90.74) | Rel Volume | 0.75 | Prev Close | $79.47 |
| Employees | 655 | LT Debt/Eq | 0.44 | EPS/Sales Surpr. | -8.27% -1.53% | SMA200 | -16.94% ($94.87) | Avg Volume(3M) | 0.36M | Price | $78.8 |
| IPO | 2006/10/19 | Option/Short | Yes/Yes | Trades | 5342 | Volume | 274,623 | Change | -0.84% |
Company
LMAT is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩸 This is a US-based company that develops and supplies medical devices for the treatment of peripheral vascular diseases. It offers a diverse range of niche medical devices used in peripheral vascular surgery, including vascular grafts and shunts, catheters, and patches, and grows through a specialized product portfolio and acquisition strategy targeting vascular surgeons. The company has established itself as a medical device provider focused on the peripheral vascular field.
Over the past 1 year, on the lower side
33% below its 1-year high.
LMAT makes money exceptionally well
29.46% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +14.0% this year.
Tap to view numbers
The price looks about right
Trading at 28.1 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +41.2% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 1.27% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 100.8%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SCDV 0.03%
DVGR 0.02%
MDEV 0.02%
XHE 0.02%
SAWS 0.01%It ranks #4 in the industry
Based on market cap of $2B.
LMAT $2B PER 28.1
ISRG $127B PER 41.3
BDX $48B PER 53.2
MDLN $43B PER 38.0
FAQ
What kind of company is LMAT?
LMAT belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of LMAT?
The market cap of LMAT is approximately $1.8B, ranking 2,184 within its sector.
Does LMAT pay dividends?
LMAT has a dividend yield of approximately 1.27%, with an annual dividend of $1.00.
What is the P/E ratio of LMAT?
LMAT has a P/E ratio of approximately 28.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for LMAT?
LMAT has recorded a 52-week high of $118.01 and a low of $78.27.
